<DOC>
	<DOC>NCT02385721</DOC>
	<brief_summary>Evaluated the incidence and characteristics of adverse events during the treatment for Kanarb tablet.</brief_summary>
	<brief_title>A Prospective, Observational, Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With KanarbÂ® (Fimasartan)</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>Clinical diagnosis of Hypertension Patients with peritoneal dialysis</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>